These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11166035)

  • 1. Characterization of DNA fragmentation events caused by genotoxic and non-genotoxic agents.
    Ploski JE; Aplan PD
    Mutat Res; 2001 Feb; 473(2):169-80. PubMed ID: 11166035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
    Beere HM; Chresta CM; Hickman JA
    Mol Pharmacol; 1996 May; 49(5):842-51. PubMed ID: 8622634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanisms underlay DNA disintegration during apoptosis induced by genotoxic and nongenotoxic agents in neuroblastoma cells.
    Solovyan V; Bezvenyuk Z; Huotari V; Tapiola T; Salminen A
    Neurochem Int; 1999 Jun; 34(6):465-72. PubMed ID: 10402221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B; Dubrez L; Allouche M; Solary E
    Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis.
    Beere HM; Chresta CM; Alejo-Herberg A; Skladanowski A; Dive C; Larsen AK; Hickman JA
    Mol Pharmacol; 1995 May; 47(5):986-96. PubMed ID: 7746285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination between genotoxicity and cytotoxicity in the induction of DNA double-strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, Triton X-100, and gamma-irradiation.
    Vock EH; Lutz WK; Hormes P; Hoffmann HD; Vamvakas S
    Mutat Res; 1998 Feb; 413(1):83-94. PubMed ID: 9602861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
    Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
    Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH
    Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells.
    Huang P; Robertson LE; Wright S; Plunkett W
    Clin Cancer Res; 1995 Sep; 1(9):1005-13. PubMed ID: 9816073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
    Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC
    Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
    Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of alkylator (melphalan) resistance in HL60 cells is accompanied by increased levels of topoisomerase II expression and function.
    Pu QQ; Bezwoda WR
    Mol Pharmacol; 1999 Jul; 56(1):147-53. PubMed ID: 10385695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage signals induction of fas ligand in tumor cells.
    Mo YY; Beck WT
    Mol Pharmacol; 1999 Feb; 55(2):216-22. PubMed ID: 9927611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
    Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkylphosphocholines: Effects on human leukemic cell lines and normal bone marrow cells.
    Konstantinov SM; Topashka-Ancheva M; Benner A; Berger MR
    Int J Cancer; 1998 Aug; 77(5):778-86. PubMed ID: 9688313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time sequential expression of markers of apoptosis induced by 1-beta-D-arabinofuranosylcytosine in human T-lymphoblastic leukemia CCRF-CEM cells.
    Badran A; Iwasaki H; Wano Y; Kishi S; Ueda T
    Anticancer Res; 2001; 21(3B):1987-95. PubMed ID: 11497288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism.
    Sleiman RJ; Catchpoole DR; Stewart BW
    Br J Cancer; 1998; 77(1):40-50. PubMed ID: 9459144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells.
    Chapman RS; Chresta CM; Herberg AA; Beere HM; Heer S; Whetton AD; Hickman JA; Dive C
    Cytometry; 1995 Jul; 20(3):245-56. PubMed ID: 7587710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.